SCHEMBL23966544

SCHEMBL23966544

CC(C)(C)OC(=O)N1CCC(n2nc(Cc3nc4cc(OC(F)(F)F)c(Cl)cc4[nH]3)c3ccccc3c2=O)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 12/20 0.62
ADRA1A P35348 3/20 0.40
HRH1 P35367 3/20 0.40
ADRA1B P35368 3/20 0.40
HRH3 Q9Y5N1 2/20 0.40
ADRA2A P08913 2/20 0.38
CHRM1 P11229 2/20 0.38
ADRA2B P18089 2/20 0.38
HTR2A P28223 2/20 0.38
DRD3 P35462 2/20 0.38
ABCB1 P08183 2/20 0.38
KCNH2 Q12809 2/20 0.38
CHRM2 P08172 1/20 0.38
ADRB1 P08588 1/20 0.38
CYP2D6 P10635 1/20 0.38
GABRA1 P14867 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914714 0.96 S1PR2 (0.60) S1PR2ADRA1AHRH1ADRA1BHRH3
SCHEMBL23915479 0.89 S1PR2 (0.67) S1PR2ADRA1AHRH1ADRA1B
SCHEMBL23914717 0.88 S1PR2 (0.66) S1PR2ADRA1AHRH1ADRA1BHRH3
SCHEMBL23908762 0.87 S1PR2 (0.66) S1PR2ADRA1AHRH1ADRA1BHRH3
SCHEMBL23914710 0.86 S1PR2 (0.65) S1PR2ADRA1AHRH1ADRA1BPARP1
SCHEMBL23915580 0.86 S1PR2 (0.52) S1PR2ADRA1AHRH1ADRA1BHRH3
SCHEMBL23915339 0.85 S1PR2 (0.68) S1PR2LMNASMN1; SMN2TNKSPARP1
SCHEMBL23908864 0.85 S1PR2 (0.65) S1PR2ADRA1AHRH1ADRA1BHRH3
SCHEMBL23908806 0.84 S1PR2 (0.64) S1PR2ADRA1AHRH1ADRA1BHRH3
SCHEMBL23913181 0.84 S1PR2 (0.62) S1PR2ADRA1AHRH1ADRA1BHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed